Evolving focus on diastolic dysfunction in patients with coronary artery disease

Current Opinion in Cardiology

Volumn 25, Issue 6, 2010, Pages 613-621

  Ohara, Takahiro ^a   Little, William C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

coronary artery disease; diastolic dysfunction; heart failure with preserved ejection fraction

Indexed keywords

AMLODIPINE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CHLORTALIDONE; DIGOXIN; DOXAZOSIN; IRBESARTAN; LISINOPRIL; NEBIVOLOL; PERINDOPRIL; PLACEBO; VALSARTAN;

ACUTE CORONARY SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIASTOLIC DYSFUNCTION; EXERCISE TEST; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; TAKOTSUBO CARDIOMYOPATHY;

ACUTE CORONARY SYNDROME; CORONARY ARTERY DISEASE; DIASTOLE; HEART VENTRICLES; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREVALENCE; PROGNOSIS; STROKE VOLUME; TAKOTSUBO CARDIOMYOPATHY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 78049244457     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32833f0438     Document Type: Review

References (75)

1. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355:251-259. (Pubitemid 44079340)
2. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA 2006; 296:2209-2216. (Pubitemid 44708051)
3. Gaasch WH, Delorey DE, Kueffer FJ, et al. Distribution of left ventricular ejection fraction in patients with ischemic and hypertensive heart disease and chronic heart failure. Am J Cardiol 2009; 104:1413-1415.
4. Little WC. Diastolic dysfunction beyond distensibility: adverse effects of ventricular dilatation. Circulation 2005; 112:2888-2890.
5. Tan YT, Wenzelburger F, Lee E, et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 2009; 54: 36-46.
6. Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. Acute neurohumoral modulation of diastolic function. Peptides 2009; 30:419-425.
7. Ishii K, Suyama T, Imai M, et al. Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention: clinical significance of postischemic diastolic stunning. J Am Coll Cardiol 2009; 54:1589-1597.
8. Sengupta PP, Tajik AJ, Chandrasekaran K, et al. Twist mechanics of the left ventricle: principles and application. JACC Cardiovasc Imaging 2008;1:366-376. (Pubitemid 351676845)
9. Bertini M, Nucifora G, Marsan NA, etal. Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients. Am J Cardiol 2009; 103:1506-1512.
10. Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003; 89:54-60. (Pubitemid 36044290)
11. Yu CM, Zhang Q, Yip GW, et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: A common but ignored condition. J Am Coll Cardiol 2007; 49:97-105. (Pubitemid 46039794)
12. Lee PW, Zhang Q, Yip GW, et al. Left ventricular systolic and diastolic dyssynchrony in coronary artery disease with preserved ejection fraction. Clin Sci (Lond) 2009; 116:521-529.
13. Kosmala W, Derzhko R, Przewlocka-Kosmala M, et al. Plasma levels of TNF-alpha, IL-6, and IL-1 0 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coron Artery Dis 2008; 19:375-382.
14. Williams ES, Shah SJ, Ali S, et al. C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study. Eur J Heart Fail 2008; 10:63-69.
15. Tsougos E, Panou F, Paraskevaidis I, et al. Exercise-induced changes in E/E' ratio in patients with suspected coronary artery disease. Coron Artery Dis 2008; 19:405-411.
16. Nakajima Y, Kane GC, McCully RB, et al. Left ventricular diastolic filling pressures during dobutamine stress echocardiography: relationship to symptoms and ischemia. J Am Soc Echocardiogr 2009; 22:947-953.
17. Ishii K, Imai M, Suyama T, et al. Exercise-induced postischemic left ventricular delayed relaxation or diastolic stunning: is it a reliable marker in detecting coronary artery disease? J Am Coll Cardiol 2009; 53:698-705.
18. Paraskevaidis IA, Tsougos E, Panou F, et al. Diastolic stress echocardiogra phy detects coronary artery disease in patients with asymptomatic type II diabetes. Coron Artery Dis 2010; 21:104-112.
19. Hoffmann S, Mogelvang R, Olsen NT, et al. Tissue Doppler echocardiography bull; reveals distinct patterns of impaired myocardial velocities in different degrees of coronary artery disease. Eur J Echocardiogr 2010; 11:602-607.
20. Park SM, Prasad A, Rihal C, et al. Left ventricular systolic and diastolic function in patients with apical ballooning syndrome compared with patients with acute anterior ST-segment elevation myocardial infarction: A functional paradox. Mayo Clin Proc 2009; 84:514-521.
21. Carluccio E, Biagioli P, Alunni G, et al. Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy. Eur Heart J 2009; 30:1501-1509.
22. Yao K, Huang R, Qian J, et al. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart 2008; 94:1147-1153.
23. Plewka M, Krzeminska-Pakula M, Lipiec P, et al. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction. Am J Cardiol 2009; 104:1336-1342.
24. Esmaeilzadeh M, Khaledifar A, Maleki M, et al. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction. Eur J Echocardiogr 2009; 10:120-126.
25. Skubas N. Intraoperative Dopplertissue imaging is a valuable addition to cardiac anesthesiologists' armamentarium: A core review. Anesth Analg 2009; 108:48-66.
26. Moller JE, Sondergaard E, Seward JB, et al. Ratio of left ventricular peak E-wave velocity to flow propagation velocity assessed by color M-mode Doppler echocardiography in first myocardial infarction: prognostic and clinical implications. J Am Coll Cardiol 2000; 35:363-370. (Pubitemid 30125526)
27. Ueno Y, Nakamura Y, Kinoshita M, et al. An early predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction: ratio of peak E wave velocity/flow propagation velocity and mitral E wave deceleration time. Echocardiography 2002; 19:555-563. (Pubitemid 35253406)
28. Meta-Analysis Research Group in Echocardiography (Me RGE) AMI Collaborators, Moller JE, Whalley GA, et al. Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: Meta-Analysis Research Group in Echo cardiography acute myocardial infarction. Circulation 2008;117:2591-2598.
29. Khumri TM, Reid KJ, Kosiborod M, et al. Usefulness of left ventricular diastolic dysfunction as a predictor of one-year rehospitalization in survivors of acute myocardial infarction. Am J Cardiol 2009; 103:17-21.
30. Richardson-Lobbedez M, Marechaux S, Bauters C, et al. Prognostic importance of tissue Doppler-derived diastolic function in patients presenting with acute coronary syndrome: A bedside echocardiographic study. Eur J Echo cardiogr 2008; 9:594-598.
31. Shanks M, Ng AC, van de Veire NR, et al. Incremental prognostic value of novel left ventricular diastolic indexes for prediction of clinical outcome in patients with ST-elevation myocardial infarction. Am J Cardiol 2010; 105:592-597.
32. Jons C, Joergensen RM, Hassager C, et al. Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: A CARISMA substudy. Eur J Echocardiogr 2010; 11:602-607.
33. Khumri TM, Walker BL, Magalski A, et al. Combined assessment of myo-cardial perfusion and diastolic function enhances risk stratification in patients with anterior wall myocardial infarction. Echocardiography 2009; 26:61-65.
34. Ren X, Na B, Ristow B, et al. Usefulness of diastolic dominant pulmonary vein flow to predict hospitalization for heart failure and mortality in ambulatory patients with coronary heart disease (from the Heart and Soul Study). Am J Cardiol 2009; 103:482-485.
35. Ristow B, Ali S, Whooley MA, et al. Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). Am J Cardiol 2008; 102:70-76.
36. Stevens SM, Farzaneh-Far R, Na B, et al. Development of an echocardio-graphic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging 2009; 2:11-20.
37. Arruda-Olson AM, Pellikka PA, Bursi F, et al. Left ventricular function and heart failure in myocardial infarction: impact of the new definition in the community. Am Heart J 2008; 156:810-815.
38. Andersen NH, Karlsen FM, Gerdes JC, et al. Diastolic dysfunction after an acute myocardial infarction in patients with antecedent hypertension. J Am Soc Echocardiogr 2008; 21:171-177. (Pubitemid 351193105)
39. Arruda-Olson AM, Enriquez-Sarano M, Bursi F, et al. Left ventricular function and C-reactive protein levels in acute myocardial infarction. Am J Cardiol 2010; 105:917-921.
40. Gardin JM, Leifer ES, Fleg JL, et al. Relationship of Doppler-echocardio-graphic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study. Am Heart J 2009; 158 (Suppl 4): S52.
41. Farr MJ, Lang CC, Lamanca JJ, et al. Cardiopulmonary exercise variables in diastolic versus systolic heart failure. Am J Cardiol 2008; 102:203-206.
42. Sweitzer NK, Lopatin M, Yancy CW, et al. Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or 1/455%) versus those with mildly reduced (40-55%) and moderately to severely reduced (<40%) fractions. Am J Cardiol 2008; 101:1156.
43. Zile MR, Gaasch WH, Anand IS, et al. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation 2010; 121:1393-1405.
44. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112:e154-e235.
45. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM Preserved Trial. Lancet 2003; 362:777-781. (Pubitemid 37093918)
46. Cleland JGF, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27:2338-2345. (Pubitemid 44453578)
47. Solomon SD, Janardhanan R, Verma A, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomised trial. Lancet 2007; 369:2079-2087. (Pubitemid 46935945)
48. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358:1887-1898. (Pubitemid 351620109)
49. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-2467.
50. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997. (Pubitemid 35471160)
51. Davis BR, Kostis JB, Simpson LM, et al. Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Circulation 2008; 118:2259-2267.
52. Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26:215-225.
53. Van Veldhuisen DJ, Cohen-Solal A, Bohm M, et al. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with Heart Failure). J Am Coll Cardiol 2009; 53:2150-2158.
54. Hernandez AF, Hammill BG, O'Connor CM, et al. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol 2009; 53:184-192.
55. Ahmed A, Rich MW, Fleg JL, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 2006; 114:397-403. (Pubitemid 44264821)
56. Gorelik O, Almoznino-Sarafian D, Shteinshnaider M, et al. Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure. Clin Res Cardiol 2009; 98:224-232.
57. Gotsman I, Zwas D, Planer D, et al. Clinical outcome of patients with heart failure and preserved left ventricular function. Am J Med 2008; 121:997-1001.
58. Tribouilloy C, Rusinaru D, Mahjoub H, et al. Prognosis of heart failure with preserved ejection fraction: A 5-year prospective population-based study. Eur Heart J 2008; 29:339-347. (Pubitemid 351197754)
59. Lam CSP, Roger VL, Rodeheffer RJ, et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction: from Olmstead County, Minnesota. Circulation 2007; 115:1982-1990.
60. Maurer MS, Burkhoff D, Fried LP, et al. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol 2007; 49:972-981. (Pubitemid 46320198)
61. Correa de Sa DD, Hodge DO, Slusser JP, et al. Progression of preclinical diastolic dysfunction to the development of symptoms. Heart 2010; 96:528-532.
62. Poulsen MK, Hennriksen JE, Dahl J, et al. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging 2010; 3:24-31.
63. Weber T, O'Rourke MF, Ammer M, et al. Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens 2008; 21:1194-1202.
64. Lam CS, Borlaug BA, Kane GC, et al. Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 2009; 119:2663-2670.
65. From AM, Scott CG, Chen HH. The development of heart failure in patients with diabetes mellitus and preclinical diastolic dysfunction a population-based study. J Am Coll Cardiol 2010; 55:300-305.
66. Peacock WF 4th, De Marco T, Fonarow GC, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008; 358:2117-2126. (Pubitemid 351679598)
67. Ahmed A, Zile MR, Rich MW, et al. Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure. Am J Cardiol 2007; 99:460-464 (Pubitemid 46215547)
68. Rossi JS, Flaherty JD, Fonarow GC, et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). Eur J Heart Fail 2008; 10:1215-1223.
69. Flaherty JD, Bax JJ, De Luca L, et al. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Col Cardiol 2009; 53:254-263.
70. Grigorian-Shamagian L, Otero Ravina F, Abu Assi E, et al. Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study. Am Heart J 2008; 156:1184-1190.
71. Kramer K, Kirkman P, Kitzman D, et al. Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. Am Heart J 2000; 140:451-455.
72. Gandhi SK, Powers JC, Nomeir AM,etal. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344:17-22. (Pubitemid 32064840)
73. Pela G, Pattoneri P, Passera M, et al. Long-term effects of perindopril on left ventricular structure and function in patients with stable coronary artery disease: A conventional and Doppler tissue echocardiographic pilot study. J Cardiovasc Med (Hagerstown) 2009; 10:781-786.
74. Smith DT, Farzaneh-Far R, Ali S, et al. Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study). Am J Cardiol 2010; 105:223-228.
75. Qie L, Meng X, Wang Y, et al. Assessment of regional systolic and diastolic functions affected by atorvastatin in coronary artery disease using tissue Doppler imaging. Clin Cardiol 2008; 31:551-555.